Adrenocortical tumor in a boy: final height is not impaired despite a severe advancement of bone age.
The long-term sequelae on the growth pattern in successfully resected virilizing adrenal tumors (ACT) have not been clearly defined. We report on 10 years follow-up of a boy with virilizing ACT until the attainment of final height. This is the first clinical description in a boy with a marked advancement of bone age, indicating that despite advanced physical and skeletal maturity the prognosis on growth is good, provided that regression of virilization is obtained.
D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000236:Adenoma / Q000473:pathology* / Q000601:surgery; D000306:Adrenal Cortex Neoplasms / Q000473:pathology* / Q000601:surgery; D001827:Body Height / Q000502:physiology*; D001846:Bone Development / Q000502:physiology*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D011379:Prognosis; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D019326:17-alpha-Hydroxyprogesterone